Skip to main content
. 2021 Jan 19;5(2):298–307. doi: 10.1016/j.mayocpiqo.2020.10.009

Table 2.

Clinical Symptoms

Clinical symptom N Overall (N=110) Nontransplant patients (n=56) Transplant patients (n=54) P value
Cough 110 50 (45.5) 22 (39.3) 28 (51.9) .19
Dyspnea 110 44 (40.0) 17 (30.4) 27 (50.0) .036
Sputum production 110 31 (28.2) 15 (26.8) 16 (29.6) .74
Fever 110 28 (25.5) 8 (14.3) 20 (37.0) .006
Cutaneous lesions 110 22 (20.0) 15 (26.8) 7 (13.0) .07
Other 110 17 (15.5) 9 (16.1) 8 (14.8) .86
Asthenia 110 16 (14.5) 5 (8.9) 11 (20.4) .089
Chills 110 15 (13.6) 7 (12.5) 8 (14.8) .72
Chest pain 110 9 (8.2) 3 (5.4) 6 (11.1) .27
Weight loss 110 7 (6.4) 5 (8.9) 2 (3.7) .26
Focal neurological signs 110 6 (5.5) 6 (10.7) 0 (0.0) .013
Headache 110 4 (3.6) 1 (1.8) 3 (5.6) .29
Seizures 110 2 (1.8) 2 (3.6) 0 (0.0) .16
Arthritis 110 2 (1.8) 2 (3.6) 0 (0.0) .16
Acute respiratory distress syndrome 110 1 (0.9) 1 (1.8) 0 (0.0) .32
Coma 110 1 (0.9) 1 (1.8) 0 (0.0) .32

Data are presented as No. (percentage). P values comparing nontransplant and transplant patient results from the Fisher exact test.